Chinese Academy of Medical Science, People's Republic of China
Research from the People's Republic of China, Germany and Belgium in diagnostics provides new insights
Published in Cardiovascular Device Liability Week, July 23rd, 2006
Study 1: Normal exercise Tc-99m-sestamibi myocardial single photon emission computed tomography (SPECT) despite angiographic coronary artery disease (CAD) suggests a low rate of cardiac death or non-fatal myocardial infarction but a relatively high rate of late revascularization during an intermediate term of follow-up.
According to recent research from People's Republic Of China, "Previous studies have documented the prognostic value of normal exercise (TI)-T-201 myocardial perfusion imaging in patients with angiographic coronary artery disease...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- 3F Therapeutics
ATS Medical extends definitive agreement to acquire 3F Therapeutics - Children's Hospital, Boston, U.S.
77% of pediatric patients were bridged to transplantation with ventricular assist device support - Robarts Research Institute, Canada
3D coronary angiography gating technique provides angle-independent measure of motion - St. Vincent's Hospital, Fitzroy, Australia
AF treatment with the Cox-Maze III procedure is still effective and safe
Cardiac care patterns were monitored successfully by The Clinical Outcomes Assessment Program
Post-myocardial infarction mortality could be reduced with modest increases in statin prescription- More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
